509 patients with ER-positive, HER2-negative, lymph node negative tumors up to 2 cm who received no adjuvant systemic therapy were matched one-to-one to patients with similar tumor features treated with adjuvant endocrine therapy. This evidence concerns the gene ESR1 and neoplasm.